Home » Topics » BioWorld Science

BioWorld Science
RSS

ERRalpha inverse agonist shows significant in vivo activity against breast cancer

Dec. 31, 2021

Piperine-based derivatives identified with activity against breast cancer cells

Dec. 31, 2021

New PD-1/PD-L1 interaction inhibitors identified at Kainos Medicine

Dec. 31, 2021

Kinnate Biopharma discovers FGFR inhibitors

Dec. 31, 2021

CSPC Zhongqi Pharmaceutical Technology patents PTPN11 inhibitors

Dec. 31, 2021

New CDK7 inhibitors presented by ScinnoHub Pharmaceutical

Dec. 31, 2021

Medshine Discovery identifies new NLRP3 inflammasome inhibitors

Dec. 31, 2021

Carnitine metabolite has role in cognitive aging

Dec. 31, 2021

High-throughput screening assay to identify inhibitors of SARS-CoV-2 Mac1 macrodomain

Dec. 30, 2021

Peripheral delivery of the brain permeable AMPK activator R-481 raises glycemia in rats

Dec. 30, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...